Molecular Partners AG (MOLN)
5.08
-0.14
(-2.68%)
USD |
NASDAQ |
Dec 20, 16:00
5.18
+0.10
(+1.97%)
After-Hours: 20:00
Molecular Partners Shareholders Equity (Quarterly): 164.96M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 154.72M |
| CRISPR Therapeutics AG | 1.940B |
| Addex Therapeutics Ltd | 13.15M |
| NLS Pharmaceutics Ltd | -9.268M |
| MoonLake Immunotherapeutics | 488.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.31M |
| Total Liabilities (Quarterly) | 18.34M |
| Current Ratio | 14.33 |